How Venture Studios Generate 3-5x Returns for LPs (While VCs Average 2.5x)
Sunday, 26 April 2026
Venture studios make money for LPs through a fundamentally different model than traditional VCs — they build and de-risk companies from inception, typically capturing 20-50% equity stakes while reducing failure rates from 90% to 60-70%. This operational approach generates returns of 3-5x compared to the VC industry average of 2.5x, primarily because studios control more
- Published in Founder Resources, Startup Strategy
No Comments
The NIL Deal Trap: Why 73% of Athlete Entrepreneurs Fail in Year One (And the Framework That Changes Everything)
Sunday, 26 April 2026
NIL deal entrepreneurship is the emerging business model where college athletes monetize their name, image, and likeness through partnerships, sponsorships, and equity deals—transforming 460,000+ NCAA athletes into instant entrepreneurs overnight. But here’s what nobody tells you: 73% of these athlete ventures fail within their first year, not because they lack talent or audience, but because
- Published in Founder Resources, Startup Strategy
Why Your B2B Fan Engagement Data Platform Is Collecting Metrics Nobody Actually Uses (And The Framework That Changes Everything)
Saturday, 25 April 2026
A fan engagement data platform for B2B isn’t just another analytics dashboard—it’s the difference between knowing who clicked your content and understanding which behaviors predict $100K+ deals. Yet most B2B founders we work with are sitting on mountains of engagement data they never actually use to drive revenue decisions. Here’s what nobody tells you: 80%
- Published in Founder Resources, Startup Strategy
The Hidden Cost of Waiting: Why B2B Founders Are Racing to Implement Clinical Decision Support AI
Saturday, 25 April 2026
Picture this: A founder at $800K ARR watches competitors land $2M enterprise deals with major health systems while they’re still pitching rule-based decision trees. Clinical decision support AI implementation is the strategic capability that separates B2B healthcare companies that scale from those that stall — it’s the difference between being a vendor and becoming critical
- Published in Founder Resources, Startup Strategy









